Health officials to weigh limits on J&J vaccine as deadly blood clots continue
By Jesse O’Neill
December 15, 2021 10:48pm
The Centers for Disease Control and Prevention was set to meet with advisers Thursday to discuss possible restrictions on Johnson & Johnson’s COVID-19 vaccine due to ongoing concerns about blood clots, particularly among women.
Federal officials temporarily halted use of the single dose J&J vaccine in April to study six women who had experienced blood clots after getting vaxxed. The government ruled that the rewards far outweighed the risks associated with the shot, and usage of the vaccine resumed within days with a new warning label.
Although complications remain rare, some nine American women have died after experiencing blood clots associated with the vaccine, and the rate of clots in people who received it has increased since April, the Washington Post reported Wednesday.
About one woman per 100,000 aged 30 to 49 had experienced clot issues after getting a J&J jab, the FDA said in a fact sheet released Tuesday.
more
https://nypost.com/2021/12/15/health-officials-to-weigh-limits-on-jj-vaccine-due-to-blood-clots/
